Latest filing published 17 Dec 2018 for ONCOSEC MEDICAL Inc, €1,022.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James M. Demesa: trading record in brief
James M. Demesa is a declared insider of ONCOSEC MEDICAL Inc, with filings sourced from SEC (Form 4). Between 1 March 2011 and 17 December 2018, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €6,136. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. So far in 2018, the count stands at 2 purchases and no sales.
The median purchase comes to €1,193.
On 17 December 2018 came the latest disclosure, a share grant for €1,022 in ONCOSEC MEDICAL Inc. The most recent open-market purchase was published on 26 November 2018, 2,905 days ago. Typically, a trade is published a median of 13 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James M. Demesa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$0.7714.4% of flowCommon StockSEC:0001493152-18-017619:0
- 1,500 shares@ US$0.9116.8% of flowCommon StockSEC:0001493152-18-016700:0Canonical exit: 5 Feb 2019 (T+90)
- 7,000 shares@ US$0.8068.8% of flowCommon StockSEC:0001493152-18-016700:1Canonical exit: 18 Feb 2019 (T+90)
- 250,000 shares@ US$0.0003Common StockSEC:0001179110-11-005395:0Canonical exit: 30 May 2011 (T+90)
4 of 4 declarations
